Inventor · disambiguated record
Matthias Gromeier
Also filed as: GROMEIER MATTHIAS
15 granted patents·7 pending applications·110 citations·filing 1998–2025
91Inventor score
Top patents by PatentIndex Score
22 records- 0192US11813298B2Oncolytic poliovirus for human tumorsUNIV DUKE·Filed 2022·Granted Nov 14, 2023·1 cites·18 claims
- 0292US11406677B2Oncolytic poliovirus for human tumorsUNIV DUKE·Filed 2020·Granted Aug 9, 2022·3 cites·25 claims
- 0392US10799543B2Oncolytic poliovirus for human tumorsUNIV DUKE·Filed 2019·Granted Oct 13, 2020·4 cites·31 claims
- 0491US6518033B1Method of detecting the presence of CD155 for diagnosis of cancer and to determine treatmentUNIV NEW YORK STATE RES FOUND·Filed 2000·Granted Feb 11, 2003·53 cites·13 claims
- 0588US10398743B2Oncolytic poliovirus for human tumorsUNIV DUKE·Filed 2017·Granted Sep 3, 2019·5 cites·22 claims
- 0687US6464972B1Recombinant poliovirus for the treatment of cancerUNIV NEW YORK STATE RES FOUND·Filed 2000·Granted Oct 15, 2002·14 cites·32 claims
- 0781US11331343B2Compositions and methods for activating antigen presenting cells with chimeric poliovirusUNIV DUKE·Filed 2017·Granted May 17, 2022·1 cites·34 claims
- 0879US7147848B2Recombinant poliovirus for the treatment of cancerUNIV NEW YORK STATE RES FOUND·Filed 2002·Granted Dec 12, 2006·7 cites·7 claims
- 0976US11065332B2Combination therapy of immunotoxin and checkpoint inhibitorUNIV DUKE·Filed 2016·Granted Jul 20, 2021·1 cites·22 claims
- 1076US2024350624A1Combination Therapy of Immunotoxin and Checkpoint InhibitorUNIV DUKE·Filed 2024·Application pending·0 cites
- 1172US2025241969A1Neoadjuvant cancer treatmentUNIV DUKE·Filed 2025·Application pending·0 cites
- 1269US6264940B1Recombinant poliovirus for the treatment of cancerUNIV NEW YORK STATE RES FOUND·Filed 1998·Granted Jul 24, 2001·20 cites·22 claims
- 1365US2021338811A1Combination Therapy of Immunotoxin and Checkpoint InhibitorUNIV DUKE·Filed 2021·Application pending·0 cites
- 1463US11428691B2Methods for predicting tumor response to immunotherapyUNIV DUKE·Filed 2019·Granted Aug 30, 2022·0 cites·15 claims
- 1563US2021106633A1Neoadjuvant cancer treatmentUNIV DUKE·Filed 2019·Application pending·0 cites
- 1661US2016030497A1Oncolytic poliovirus for human tumorsUNIV DUKE·Filed 2013·Application pending·0 cites
- 1760US7968086B2Genetically stable enterovirus expression vector with replaced stem loop VIUNIV DUKE·Filed 2002·Granted Jun 28, 2011·1 cites·11 claims
- 1860US2020368300A1Combination TreatmentUNIV DUKE·Filed 2020·Application pending·0 cites
- 1955US10744170B2Combination treatmentUNIV DUKE·Filed 2016·Granted Aug 18, 2020·0 cites·27 claims
- 2054US2022387529A1Treatment for primary and metastatic cancerUNIV DUKE·Filed 2020·Application pending·0 cites
- 2153US11506666B2Detection of CD-155, the poliovirus receptorUNIV DUKE·Filed 2017·Granted Nov 22, 2022·0 cites·17 claims
- 2242US10744171B2Sequential anti-cancer treatmentUNIV DUKE·Filed 2017·Granted Aug 18, 2020·0 cites·24 claims
Join the waitlist — get patent alerts
Get an alert when Matthias Gromeier files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →